PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 3780065

DERM/PHARM. Drug data base for dermatologists.

S Maddin·R S Stern
View original source ↗Export metadata ↓

Abstract

DERM/PHARM (drugs used in dermatology) is computerized data base that presents drug profiles on the more than 300 drugs used for the treatment of skin disease. This data base can be accessed through DERM/INFONET by members of the American Academy of Dermatology. This data base will be maintained by the Task Force on DERM/PHARM of the Committee on Biomedical Communications of the American Academy of Dermatology.

Explore related subjects

Drug Therapy, Computer-AssistedHumansOnline SystemsSkin DiseasesTherapy, Computer-AssistedUnited StatesJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

S Maddin, R S Stern. 1986. DERM/PHARM. Drug data base for dermatologists.. https://pubmed.ncbi.nlm.nih.gov/3780065/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2005

Overriding of drug safety alerts in computerized physician order entry.

Many computerized physician order entry (CPOE) systems have integrated drug safety alerts. The authors reviewed the literature on physician response to drug safety alerts and interpreted the results using Reason's framework of accident causation. In total, 17 papers met the inclusion criteria. Drug safety alerts are overridden by clinicians in 49% to 96% of cases. Alert overriding may often be justified and adverse drug events due to overridden alerts are not always preventable. A distinction between appropriate and useful alerts should be made. The alerting system may contain error-producing conditions like low specificity, low sensitivity, unclear information content, unnecessary workflow disruptions, and unsafe and inefficient handling. These may result in active failures of the physician, like ignoring alerts, misinterpretation, and incorrect handling. Efforts to improve patient safety by increasing correct handling of drug safety alerts should focus on the error-producing conditions in software and organization. Studies on cognitive processes playing a role in overriding drug safety alerts are lacking.

Drug Therapy, Computer-Assisted↗